(secondQuint)A Multicenter Registry of Adalimumab in Chinese Adult Patients With Active Ankylosing Spondylitis.

 This registry will be conducted in a non-interventional setting for AS patients using adalimumab in China.

The primary objective is to evaluate the effectiveness and safety of adalimumab in Chinese AS patients in real world clinical practice.

The secondary objective is to 1)compare the clinical outcome in patients with or without good persistence with adalimumab;2)investigate the predicting factors of a good clinical response after discontinuation of adalimumab.

.

 A Multicenter Registry of Adalimumab in Chinese Adult Patients With Active Ankylosing Spondylitis@highlight

A multicenter registry to explore the clinical outcome of Chinese adult patients with active Ankylosing Spondylitis *AS* treated with adalimumab,prescribed according to the local label,in the real world practice